Metraipolis › archive › dc_c4a808df7de6

Six promising drug repurposing candidates for Alzheimer's disease and their sex-specific mechanisms and efficacy — Europe PMC PMID:40808416

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40808416
DOI
10.4103/nrr.nrr-d-25-00256
License (as archived)
solo-consultazione
Archived
2026-11-10T16:17:11.689Z
SHA-256 of the archived text
d910e9131de5f8e679aed790e7d1c1a5d36c24bf58f5d7c1baefa75f70d449bd
Stable URL of this page
https://metraipolis.com/documento/dc_c4a808df7de6

How to cite

Six promising drug repurposing candidates for Alzheimer's disease and their sex-specific mechanisms and efficacy — Europe PMC PMID:40808416 — Europe PMC (en), https://europepmc.org/article/MED/40808416 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c4a808df7de6 (Metraipolis archive dc_c4a808df7de6, sha256 d910e9131de5f8e679aed790e7d1c1a5d36c24bf58f5d7c1baefa75f70d449bd)
BibTeX
@misc{dcc4a808df7de6,
  title = {Six promising drug repurposing candidates for Alzheimer's disease and their sex-specific mechanisms and efficacy — Europe PMC PMID:40808416},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40808416},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c4a808df7de6; sha256 d910e9131de5f8e679aed790e7d1c1a5d36c24bf58f5d7c1baefa75f70d449bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40808416. Agents can read the archived copy with the MCP tool read_document.